Lifeport Sciences LLC v. Endologix, Inc.

On July 9, 2015, the U.S. District Court for the District of Delaware issued an order construing several claim terms of the patents asserted in the underlying case.  In the underlying case, Lifeport Sciences LLC (“Plaintiff”) accused Endologix, Inc. (“Defendant”) of infringement of U.S. Patent Nos. 5,489,295 (“the ‘295 Patent”), 5,676,696 (“the ‘696 Patent”), 5,993,481 (“the ‘481 Patent”), and 6,302,906 (“the ‘906 Patent”).  The ‘295 Patent, the ‘696 Patent, the ‘481 Patent, and the ‘906 Patent are drawn to an endovascular graft having bifurcation, modular bifurcated intraluminal grafts, and/or a system for delivering a prosthesis.  The U.S. District Court for the District of Delaware construed several claim terms of the various patents, including, for example, “first expandable attachment means,” “dividing means,” “connecting means,” “attaching means,” “to contain,” “first introducer,” and “engages and becomes secured within.”  The case remains pending and is captioned 1-12-cv-01791.

By: Jacqueline A. DiRamio

View Attachment (PDF)